Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
A long‐term, inappropriate, and excessive inflammatory process contributes importantly to the progressive myocardial deterioration that occurs after AMI and that occurs in patients with HF.
The concept that the progressive deterioration of cardiac function seen in both AMI and HF is in part caused by an excessive persistent inflammatory response has a compelling experimental basis supporting its validity 11, 12. For example, in the setting of AMI, there is a subgroup of patients whose progressive deterioration in left ventricular function is not caused solely by the AMI‐induced magnitude of myocardial damage, but involves other mechanisms 13. Chronic inflammation has been postulated as being one of these mechanisms responsible for progressive myocardial dysfunction in AMI, and also in HF 11, 12, 13, 14, 15
Systemic anti‐inflammatory effects of MSCs constitute one of the major mechanisms by which MSCs may improve left ventricular function.
Any myocardial benefit provided by stem cell administration is undoubtedly not caused by repopulating the damaged myocardium with new myocytes, but rather by paracrine activities with a diverse array of beneficial effects 12, 16, 17.